HOOKIPA Pharma Inc.HOOKNASDAQ
Loading
| Metric | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Revenue Growth | -51.85% | -31.51% | -81.72% | -94.52% | +426.74% |
| Gross Profit Growth | -28.85% | -26.29% | -77.91% | -87.80% | +426.74% |
| EBITDA Growth | +0.00% | +0.00% | +0.00% | -200.09% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | -260.94% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | -207.26% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +0.00% | -206.96% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | -207.89% | +0.00% |
| Weighted Average Shares Growth | +51.72% | +13.59% | +11.16% | -4.08% | +1.15% |
| Weighted Average Shares Diluted Growth | +51.61% | +13.59% | +11.16% | -0.44% | +1.15% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | +10.26% | +8.42% | +22.83% | -73.00% | -57.88% |
| Inventory Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Asset Growth | -34.57% | -33.10% | -48.84% | -58.01% | -57.85% |
| Book Value per Share Growth | -49.50% | -33.50% | -48.73% | -66.01% | -67.05% |
| Debt Growth | +14.44% | -26.70% | -86.66% | -90.20% | -88.85% |
| R&D Expense Growth | +0.22% | -36.79% | -38.45% | -36.24% | -54.80% |
| SG&A Expenses Growth | -11.25% | +37.05% | +77.42% | +69.77% | +15.08% |